Table 4.

Correlations between Δlog glucose infusion rate and changes in metabolic or anthropometric parameters by the administration of empagliflozin.

Variables	Δlog glucose infusion rate
	r	P-value
ΔUrinary glucose excretion, g/day	0.19	0.46
ΔFasting plasma glucose concentration, mmol/L	0.022	0.93
ΔMean plasma glucose concentration, mmol/L	−0.051	0.84
Δs.d. value in plasma glucose profiles	−0.55	0.016a
ΔFasting serum C-peptide, ng/mL	−0.32	0.18
ΔFasting serum C-peptide index	−0.10	0.67
ΔBMI, kg/m2	−0.43	0.056
ΔBody fat mass, kg	−0.092	0.71
ΔSkeletal muscle mass, kg	−0.082	0.74
ΔAspartate transaminase, IU/L	−0.40	0.066
ΔAlanine transaminase, IU/L	−0.39	0.092
ΔSerum uric acid, μmol/L	−0.40	0.080

Serum C-peptide indexes were calculated as serum C-peptide levels divided by plasma glucose levels. Values were assessed via Pearson’s correlation coefficient. Values in bold ^a indicate P < 0.05